retatrutide news today october 2025 Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more at our link in bio retatrutide news october 2025 Eli

Medical conditions requiring caution Several medical conditions warrant special caution or complete avoidance of Thrive GLP-1 and similar supplements

Treatment with FOXO4-DRI at 25 M in serum-limited senescent fibroblast and keloid organ culture models promoted apoptosis, decreased G0/G1 phase cells, and induced p53-pS15 nuclear exclusion confirmed by Annexin V-FITC/PI apoptosis assays and TUNEL staining of keloid organ cultures at days 3, 7, and 10

Current guidelines from the American Society of Anesthesiologists recommend holding GLP-1 medications before elective surgery due to the risk of aspiration from delayed gastric emptying

10.2337/dc24-S011 Diabetes Care

They can still enjoy a meal, but the urgency is gone